BRUKER CORPORATION Derivative Asset, Current
BRUKER CORPORATION (BRKR) had Derivative Asset, Current of $0 as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DerivativeAssetsCurrent · last filed 2026-02-27
- 2025-12-31: Derivative Asset, Current $0.00.
- 2025-09-30: Derivative Asset, Current $1.90M.
- 2025-06-30: Derivative Asset, Current $7.30M.
- 2025-03-31: Derivative Asset, Current $9.50M.
| Period end | Derivative Asset, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2025-09-30 | $1.90M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $7.30M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $9.50M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $10.70M 10-K · filed 2026-02-27 |
| 2024-03-31 | $11.80M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $12.00M 10-K · filed 2025-03-03 |
| 2022-12-31 | $14.80M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |